Robert Horsburgh

C. Robert Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health


Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is the Vice-President of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • - Boston Medical Center


  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Classes Taught

  • SPHEP730


  • Published on 8/28/2023

    Kalva J, Babu SP, Narasimhan PB, Raghupathy K, Ezhumalai K, Knudsen S, Horsburgh CR, Hochberg N, Salgame P, Roy G, Ellner J, Sarkar S. Predictors of weight loss during the intensive phase of tuberculosis treatment in patients with drug-susceptible pulmonary tuberculosis in South India. J Public Health (Oxf). 2023 Aug 28; 45(3):545-552. PMID: 36451280.

    Read At: PubMed
  • Published on 8/1/2023

    Acuña-Villaorduña C, Jacobson KR, Horsburgh CR, Canning M, Sinha P. Initial experience with BPaL-based regimens to treat multidrug-resistant TB. Int J Tuberc Lung Dis. 2023 Aug 01; 27(8):649-650. PMID: 37491751.

    Read At: PubMed
  • Published on 7/28/2023

    Hu Z, Liu K, Zhou M, Jiang X, Feng Y, Yu Z, Li Y, Chen S, Wu Q, Wang W, Horsburgh CR, Zhang Y, Zhou L, Chen B, Hu C, Martinez L. Mass tuberculosis screening among the elderly: A population-based study in a well-confined rural county in eastern China. Clin Infect Dis. 2023 Jul 28. PMID: 37506258.

    Read At: PubMed
  • Published on 7/3/2023

    Esmail H, Coussens AK, Thienemann F, Sossen B, Mukasa SL, Warwick J, Goliath RT, Davies NO, Douglass E, Jackson A, Lakay F, Streicher E, Munro JE, Barrios MH, Heinsohn T, Macpherson L, Sheerin D, Aziz S, Serole K, Daroowala R, Taliep A, Ahlers P, Malherbe ST, Bowden R, Warren R, Walzl G, Via LE, Bahlo M, Jacobson KR, Horsburgh CR, Salgame P, Alland D, Barry CE, Flynn JL, Ellner JJ, Wilkinson RJ. High resolution imaging and five-year tuberculosis contact outcomes. medRxiv. 2023 Jul 03. PMID: 37461515.

    Read At: PubMed
  • Published on 7/1/2023

    Martinez L, Warren JL, Harries AD, Croda J, Espinal MA, Olarte RAL, Avedillo P, Lienhardt C, Bhatia V, Liu Q, Chakaya J, Denholm JT, Lin Y, Kawatsu L, Zhu L, Horsburgh CR, Cohen T, Andrews JR. Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis. Lancet Public Health. 2023 Jul; 8(7):e511-e519. PMID: 37393090.

    Read At: PubMed
  • Published on 6/15/2023

    Burman W, Fox GJ, Horsburgh CR. Treatment Strategy for Rifampin-Susceptible Tuberculosis. N Engl J Med. 2023 Jun 15; 388(24):2296-2297. PMID: 37314714.

    Read At: PubMed
  • Published on 6/14/2023

    Barathi A, Krishnamoorthy Y, Sinha P, Horsburgh C, Hochberg N, Johnson E, Salgame P, Govindarajan S, Senbagavalli PB, Lakshinarayanan S, Roy G, Ellner J, Sarkar S. Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis. J Public Health (Oxf). 2023 Jun 14; 45(2):304-311. PMID: 35692180.

    Read At: PubMed
  • Published on 6/14/2023

    Krishnamoorthy Y, Ezhumalai K, Murali S, Rajaa S, Majella MG, Sarkar S, Lakshminarayanan S, Joseph NM, Soundappan G, Prakash Babu S, Horsburgh C, Hochberg N, Johnson WE, Knudsen S, Pentakota SR, Salgame P, Roy G, Ellner J. Development of prognostic scoring system for predicting 1-year mortality among pulmonary tuberculosis patients in South India. J Public Health (Oxf). 2023 Jun 14; 45(2):e184-e195. PMID: 36038507.

    Read At: PubMed
  • Published on 6/2/2023

    Sy KTL, Horváth-Puhó E, Sørensen HT, Szépligeti SK, Heeren TC, Thomsen RW, Fox MP, Horsburgh CR. Burden of Chronic Obstructive Pulmonary Disease Attributable to Tuberculosis: A Microsimulation Study. Am J Epidemiol. 2023 Jun 02; 192(6):908-915. PMID: 36813297.

    Read At: PubMed
  • Published on 6/1/2023

    Myers B, Carney T, Rooney J, Malatesta S, Ragan EJ, White LF, Natcheva H, Bouton TC, Weber SE, Farhat M, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Smoked drug use in patients with TB is associated with higher bacterial burden. Int J Tuberc Lung Dis. 2023 Jun 01; 27(6):444-450. PMID: 37231597.

    Read At: PubMed

News & In the Media